vs
Monte Rosa Therapeutics, Inc.（GLUE）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Monte Rosa Therapeutics, Inc.的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.7倍（$12.8M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -212.1%，领先210.0%），Monte Rosa Therapeutics, Inc.同比增速更快（38.5% vs -4.4%），Monte Rosa Therapeutics, Inc.自由现金流更多（$99.8M vs $-1.3M）
Monte Rosa Therapeutics是一家临床阶段生物技术企业，专注于研发靶向分子胶降解剂疗法，管线覆盖肿瘤、罕见遗传病及免疫疾病领域的未满足医疗需求，通过自主研发与行业合作推进创新疗法惠及全球患者。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
GLUE vs RMCF — 直观对比
营收规模更大
GLUE
是对方的1.7倍
$7.5M
营收增速更快
GLUE
高出43.0%
-4.4%
净利率更高
RMCF
高出210.0%
-212.1%
自由现金流更多
GLUE
多$101.1M
$-1.3M
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $12.8M | $7.5M |
| 净利润 | $-27.1M | $-155.0K |
| 毛利率 | — | 34.0% |
| 营业利润率 | -258.3% | 1.1% |
| 净利率 | -212.1% | -2.1% |
| 营收同比 | 38.5% | -4.4% |
| 净利润同比 | -13.5% | 81.7% |
| 每股收益（稀释后） | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLUERMCF
| Q4 25 | — | $7.5M | ||
| Q3 25 | $12.8M | $6.8M | ||
| Q2 25 | $23.2M | $6.4M | ||
| Q1 25 | $84.9M | $8.9M | ||
| Q4 24 | $60.6M | $7.9M | ||
| Q3 24 | — | $6.4M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $7.3M |
净利润GLUERMCF
| Q4 25 | — | $-155.0K | ||
| Q3 25 | $-27.1M | $-662.0K | ||
| Q2 25 | $-12.3M | $-324.0K | ||
| Q1 25 | $46.9M | $-2.9M | ||
| Q4 24 | $13.4M | $-847.0K | ||
| Q3 24 | — | $-722.0K | ||
| Q2 24 | — | $-1.7M | ||
| Q1 24 | — | $-1.6M |
毛利率GLUERMCF
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 23.6% | ||
| Q2 25 | — | 31.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 24.3% |
营业利润率GLUERMCF
| Q4 25 | — | 1.1% | ||
| Q3 25 | -258.3% | -7.0% | ||
| Q2 25 | -67.1% | -2.3% | ||
| Q1 25 | 51.9% | -30.3% | ||
| Q4 24 | 21.4% | -8.9% | ||
| Q3 24 | — | -14.3% | ||
| Q2 24 | — | -25.4% | ||
| Q1 24 | — | -21.7% |
净利率GLUERMCF
| Q4 25 | — | -2.1% | ||
| Q3 25 | -212.1% | -9.7% | ||
| Q2 25 | -53.0% | -5.1% | ||
| Q1 25 | 55.2% | -32.5% | ||
| Q4 24 | 22.2% | -10.7% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -25.9% | ||
| Q1 24 | — | -21.9% |
每股收益（稀释后）GLUERMCF
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.38 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.11 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.3M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.8M | $6.0M |
| 总资产 | $459.8M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GLUERMCF
| Q4 25 | — | $641.0K | ||
| Q3 25 | $208.3M | $2.0M | ||
| Q2 25 | $69.4M | $893.0K | ||
| Q1 25 | $78.5M | $720.0K | ||
| Q4 24 | $224.3M | $1.1M | ||
| Q3 24 | — | $973.0K | ||
| Q2 24 | — | $637.0K | ||
| Q1 24 | — | $2.1M |
股东权益GLUERMCF
| Q4 25 | — | $6.0M | ||
| Q3 25 | $245.8M | $6.1M | ||
| Q2 25 | $268.1M | $6.7M | ||
| Q1 25 | $275.2M | $7.0M | ||
| Q4 24 | $222.9M | $9.8M | ||
| Q3 24 | — | $10.5M | ||
| Q2 24 | — | $9.0M | ||
| Q1 24 | — | $10.6M |
总资产GLUERMCF
| Q4 25 | — | $20.7M | ||
| Q3 25 | $459.8M | $22.3M | ||
| Q2 25 | $359.6M | $20.1M | ||
| Q1 25 | $393.2M | $21.2M | ||
| Q4 24 | $438.7M | $21.6M | ||
| Q3 24 | — | $21.1M | ||
| Q2 24 | — | $19.0M | ||
| Q1 24 | — | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $100.4M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $99.8M | $-1.3M |
| 自由现金流率自由现金流/营收 | 781.5% | -16.9% |
| 资本支出强度资本支出/营收 | 5.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $145.0M | — |
8季度趋势，按日历期对齐
经营现金流GLUERMCF
| Q4 25 | — | $-1.2M | ||
| Q3 25 | $100.4M | $-488.0K | ||
| Q2 25 | $-34.7M | $350.0K | ||
| Q1 25 | $-45.5M | $1.2M | ||
| Q4 24 | $128.9M | $-2.1M | ||
| Q3 24 | — | $-3.5M | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | — | $129.0K |
自由现金流GLUERMCF
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $99.8M | $-544.0K | ||
| Q2 25 | $-36.4M | $182.0K | ||
| Q1 25 | $-47.1M | — | ||
| Q4 24 | $128.7M | — | ||
| Q3 24 | — | $-4.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-352.3K |
自由现金流率GLUERMCF
| Q4 25 | — | -16.9% | ||
| Q3 25 | 781.5% | -8.0% | ||
| Q2 25 | -157.0% | 2.9% | ||
| Q1 25 | -55.4% | — | ||
| Q4 24 | 212.3% | — | ||
| Q3 24 | — | -72.6% | ||
| Q2 24 | — | -40.2% | ||
| Q1 24 | — | -4.9% |
资本支出强度GLUERMCF
| Q4 25 | — | 0.5% | ||
| Q3 25 | 5.1% | 0.8% | ||
| Q2 25 | 7.3% | 2.6% | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 6.5% | ||
| Q1 24 | — | 6.6% |
现金转化率GLUERMCF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.97× | — | ||
| Q4 24 | 9.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GLUE
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
